1. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration

   • Akira Ooki
   • Kensei Yamaguchi

   Review Article 16 August 2021 Pages: 1169 - 1183

   

2. Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials

   • Akira Tsuburaya
   • Jia Guan
   • Shiro Tanaka

   Review Article 07 August 2021 Pages: 1184 - 1193

   

3. Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China

   • Yue Hu
   • Haibiao Bao
   • Bin Lu

   Original Article 21 June 2021 Pages: 1194 - 1202

   

4. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study

   • J. J. van Kleef
   • W. P. M. Dijksterhuis
   • On behalf of the Dutch Upper GI Cancer Group (DUCG)

   Original Article Open access 12 July 2021 Pages: 1203 - 1212

   

5. Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma

   • Alexander Quaas
   • Aylin Pamuk
   • Hakan Alakus

   Original Article Open access 19 May 2021 Pages: 1213 - 1226

   

6. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics

   • Haiyong Wang
   • Yongfeng Ding
   • Lisong Teng

   Original Article Open access 06 June 2021 Pages: 1227 - 1241

   

7. Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling

   • Qing Li
   • Wei Wu
   • Honggang Yu

   Original Article 02 June 2021 Pages: 1242 - 1253

   

8. FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes

   • Naziha Mansuri
   • Vanina D. Heuser
   • Laura Lehtinen

   Original Article Open access 11 June 2021 Pages: 1254 - 1263

   

9. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance

   • Kenji Harada
   • Naoya Sakamoto
   • Wataru Yasui

   Original Article 16 July 2021 Pages: 1264 - 1277

   

10. The expression of the alpha1 subunit of Na⁺/K⁺-ATPase is related to tumor development and clinical outcomes in gastric cancer

    • Kei Nakamura
    • Atsushi Shiozaki
    • Eigo Otsuji

    Original Article 12 July 2021 Pages: 1278 - 1292

    

11. Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains

    • Yao Lv
    • Chu-di Zhang
    • Zheng-yan Zhao

    Original Article Open access 12 July 2021 Pages: 1293 - 1306

    

12. Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type

    • Kentaro Imamura
    • Kenshi Yao
    • Akinori Iwashita

    Original Article 09 July 2021 Pages: 1307 - 1319

    

13. A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan

    • Yucherng Chen
    • Taeko Katayose
    • Hiroya Asou

    Original Article Open access 28 May 2021 Pages: 1320 - 1329

    

14. Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

    • Eric Van Cutsem
    • Mayur Amonkar
    • Kohei Shitara

    Original Article Open access 07 August 2021 Pages: 1330 - 1340

    

15. Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

    • Eric Van Cutsem
    • Mayur Amonkar
    • Kohei Shitara

    Correction 18 September 2021 Pages: 1341 - 1341

16. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy

    • Ziyu Li
    • Yongning Jia
    • Jiafu Ji

    Original Article 18 August 2021 Pages: 1342 - 1354

    

17. Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based on propensity matching

    • Ze-Ning Huang
    • Su-Yan
    • Chang-Ming Huang

    Original Article 13 August 2021 Pages: 1355 - 1364

    

18. Complete one-to-one correspondence between magnifying endoscopic and histopathologic images: the KOTO method II

    • Atsushi Majima
    • Mitsuo Kishimoto
    • Eiichi Konishi

    Technical Note 11 August 2021 Pages: 1365 - 1369

    

19. Comment on: “Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric cancer, 2021 Aug 5” by Kim et al.

    • Junjie Jiang
    • Lisong Teng

    Letter to the Editor 23 August 2021 Pages: 1370 - 1371

20. Reply to the letter by Junjie Jiang et al. regarding our manuscript “Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study”

    • Young Min Kim
    • Jie-Hyun Kim
    • Jong Suk Park

    Letter to the Editor 04 September 2021 Pages: 1372 - 1373

21. Letter to the editor: new response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor

    • Junjie Jiang
    • Lisong Teng

    Letter to the Editor 05 September 2021 Pages: 1374 - 1375

22. Comment on: “Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601. Gastric cancer, 2021 Aug 11” by Iwatsuki et al

    • Yongfeng Ding
    • Junjie Jiang
    • Nong Xu

    Letter to the Editor 13 September 2021 Pages: 1376 - 1377